Pharma majors put lobbyists to work to stagger tariff rollout: Reuters
As President Donald Trump threatens to impose sweeping geographic tariffs this week and rekindles discussions around industry-specific duties on drugmakers, pharmaceutical makers are lobbying the administration to buy themselves some extra time, Reuters reported Tuesday.
As President Donald Trump threatens to impose sweeping geographic tariffs this week and rekindles discussions around industry-specific duties on drugmakers, pharmaceutical makers are lobbying the administration to buy themselves some extra time, Reuters reported Tuesday.
